All eyes are on upcoming U.S.-China trade talks next week. Hopes were initially high that it could represent the first step in deescalation, but those hopes were dashed when another tit-for-tat round of tariffs hit. This time the dispute featured $16 billion in new import charges.
Adding to the pressure on prices, despite the current bull market recently passing into “longest ever” territory, are ongoing headlines concerning President Trump and his one-time associates. Trump himself tweeted that if he is impeached the stock market would crash and everyone would be poorer.
In light of all these headwinds, a number of blue chip large-cap stocks are rolling over. Here are four Dow Jones Industrial Average components that are looking ready to move lower:
Compare Brokers
Dow Titans at Risk: Boeing (BA)
Top 10 Blue Chip Stocks To Own Right Now: Cellect Biotechnology Ltd. (APOP)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.
- [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.
Top 10 Blue Chip Stocks To Own Right Now: LeMaitre Vascular, Inc.(LMAT)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on LeMaitre Vascular (LMAT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Brian Feroldi]
After the company reported fourth-quarter and full-year results, shares of LeMaitre Vascular (NASDAQ:LMAT), a medical device company focused on vascular surgery, jumped 18% as of 10:15 a.m. EST on Wednesday.
- [By Stephan Byrd]
CAS Medical Systems (NASDAQ: CASM) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.
- [By Ethan Ryder]
FRESENIUS SE &/S (NASDAQ: LMAT) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.
- [By Logan Wallace]
BidaskClub upgraded shares of LeMaitre Vascular (NASDAQ:LMAT) from a hold rating to a buy rating in a research note released on Thursday morning.
LMAT has been the subject of a number of other reports. ValuEngine lowered shares of LeMaitre Vascular from a buy rating to a hold rating in a research note on Friday, April 27th. Zacks Investment Research lowered shares of LeMaitre Vascular from a buy rating to a hold rating in a research note on Saturday, April 28th. Benchmark upgraded shares of LeMaitre Vascular from a hold rating to a buy rating and set a $40.00 price target for the company in a research note on Thursday, April 26th. Stifel Nicolaus lowered shares of LeMaitre Vascular from a buy rating to a hold rating and reduced their price target for the stock from $40.00 to $34.00 in a research note on Thursday, April 26th. Finally, Roth Capital started coverage on shares of LeMaitre Vascular in a research note on Friday, June 8th. They issued a buy rating and a $38.00 price target for the company. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of $37.71.
Top 10 Blue Chip Stocks To Own Right Now: Liberty TripAdvisor Holdings, Inc.(LTRPA)
Advisors' Opinion:- [By Lisa Levin]
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 31 percent to $12.10 following TripAdvisor Q1 earnings beat.
Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 34 percent to $15.3628 after the company posted better-than-expected Q1 earnings.
- [By Lisa Levin]
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 30 percent to $12.05 following TripAdvisor Q1 earnings beat.
Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 26 percent to $14.48 after the company posted better-than-expected Q1 earnings.
- [By Lisa Levin]
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 32 percent to $12.175 following TripAdvisor Q1 earnings beat.
Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 27 percent to $14.60 after the company posted better-than-expected Q1 earnings.
Top 10 Blue Chip Stocks To Own Right Now: One Horizon Group, Inc.(OHGI)
Advisors' Opinion:- [By Joseph Griffin]
WARNING: “One Horizon Group (OHGI) Trading Up 8.3%” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4154594/one-horizon-group-ohgi-trading-up-8-3.html.
- [By Stephan Byrd]
ADTRAN (NASDAQ: ADTN) and One Horizon Group (NASDAQ:OHGI) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.
- [By Max Byerly]
News stories about One Horizon Group (NASDAQ:OHGI) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. One Horizon Group earned a news impact score of 0.12 on Accern’s scale. Accern also assigned press coverage about the software maker an impact score of 48.1252923948361 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Top 10 Blue Chip Stocks To Own Right Now: Hemisphere Media Group, Inc.(HMTV)
Advisors' Opinion:- [By Logan Wallace]
News headlines about Hemisphere Media Group (NASDAQ:HMTV) have trended somewhat positive on Sunday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Hemisphere Media Group earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.3165791270916 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Logan Wallace]
Hemisphere Media Group Inc (NASDAQ:HMTV) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $13.45 and last traded at $13.40, with a volume of 2506 shares changing hands. The stock had previously closed at $13.10.
- [By Max Byerly]
BidaskClub downgraded shares of Hemisphere Media Group (NASDAQ:HMTV) from a strong-buy rating to a buy rating in a research note released on Thursday.
- [By Stephan Byrd]
Media stories about Hemisphere Media Group (NASDAQ:HMTV) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Hemisphere Media Group earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.2580984034566 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Top 10 Blue Chip Stocks To Own Right Now: J & J Snack Foods Corp.(JJSF)
Advisors' Opinion:- [By Joseph Griffin]
WARNING: “JPMorgan Chase & Co. Trims Stake in J & J Snack Foods Corp (JJSF)” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/4163089/jpmorgan-chase-co-trims-stake-in-j-j-snack-foods-corp-jjsf.html.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Trey Thoelcke]
If Coca-Cola is interested in expanding into snacks to be more like rival PepsiCo Inc. (NASDAQ: PEP), one place to start may be with either J&J Snack Foods Corp. (NASDAQ: JJSF) or TreeHouse Foods Inc. (NYSE: THS). They both have market caps of less than $3 million. J&J products include pretzels, desserts and more, while TreeHouse offers various snacks, baked goods and condiments. Both also have beverage offerings.
- [By Max Byerly]
Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
ValuEngine upgraded shares of J & J Snack Foods (NASDAQ:JJSF) from a hold rating to a buy rating in a research note issued to investors on Tuesday.
Top 10 Blue Chip Stocks To Own Right Now: Seaboard Corporation(SEB)
Advisors' Opinion:- [By Ethan Ryder]
Willis Investment Counsel lifted its holdings in Seaboard Co. (NYSEAMERICAN:SEB) by 8.5% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 524 shares of the company’s stock after acquiring an additional 41 shares during the period. Willis Investment Counsel’s holdings in Seaboard were worth $2,235,000 as of its most recent filing with the SEC.
Top 10 Blue Chip Stocks To Own Right Now: ProQR Therapeutics N.V.(PRQR)
Advisors' Opinion:- [By Cory Renauer]
ProQR (NASDAQ:PRQR) is developing QR-110 to treat patients with a mutation on the same gene as EDIT-101 but in a much different manner. QR-110 would require repeat injections right in the eyes to help a mutated gene produce functional copies of the CEP290 protein, while EDIT-101 is designed to repair the gene and provide a permanent solution with a single treatment.
- [By Chris Lange]
ProQR Therapeutics N.V. (NASDAQ: PRQR) shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase 1/2 clinical trial of QR-110 in patients with Leber's congenital amaurosis 10 (LCA10).
- [By Keith Speights]
Shares of ProQR Therapeutics N.V. (NASDAQ:PRQR) were up 16% as of 3:48 p.m. EDT on Monday. ProQR didn't report any new announcements, but the biotech's update last Wednesday from a phase 1/2 clinical study -- of RNA medicine QR-110, in treating Leber congenital amaurosis type 10 (LCA10) -- still had investors fired up.
- [By Stephan Byrd]
ProQR Therapeutics (NASDAQ:PRQR) announced its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.42) by $0.15, Zacks reports.
- [By Brian Feroldi]
After reporting data from a phase 1/2 clinical trial, shares of ProQR Therapeutics N.V. (NASDAQ:PRQR), a clinical-stage biotech focused on RNA medicines that treat rare genetic diseases, rose 70% as of 12:13 p.m. EDT on Wednesday.
Top 10 Blue Chip Stocks To Own Right Now: Dynatronics Corporation(DYNT)
Advisors' Opinion:- [By Logan Wallace]
Get a free copy of the Zacks research report on Dynatronics (DYNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
News articles about Dynatronics (NASDAQ:DYNT) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dynatronics earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 45.8383718108453 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
- [By Stephan Byrd]
Dynatronics (NASDAQ: DYNT) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.
Top 10 Blue Chip Stocks To Own Right Now: Randgold Resources Limited(GOLD)
Advisors' Opinion:- [By Maxx Chatsko]
Nonetheless, there are many smaller players with slick investor presentations making promises of big rewards. That could sound intriguing if you've caught the gold bug, but it's important to remember the risks involved when investing in the industry. Luckily, some gold stocks come with big red flags and flashing red lights. Here's why investors might want to avoid Hecla Mining (NYSE:HL), Tahoe Resources (NYSE:TAHO), and Randgold Resources (NASDAQ:GOLD).
- [By Jon C. Ogg]
Randgold Resources Ltd. (NASDAQ: GOLD) trades close to $65.50, with a $6.5 billion market cap and a 52-week range of $62.55 to $108.29. The consensus analyst target of $99.84 is barely $3.00 lower than it was just 90 days ago. The analysts are still targeting the share price to be 50% higher.
- [By Todd Campbell]
If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let's learn more about them.
- [By Shane Hupp]
Randgold Resources (NASDAQ:GOLD) was downgraded by analysts at Deutsche Bank from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Marketbeat Ratings reports. They currently have a $12.75 target price on the basic materials company’s stock, down from their prior target price of $14.00. Deutsche Bank’s price objective points to a potential downside of 1.54% from the company’s current price.
No comments:
Post a Comment